1. Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells
   Brady G. Strittmatter et al, 2021, PLOS Genetics CrossRef
2. Identification and characterization of PKF118-310 as a KDM4A inhibitor
   Gianluigi Franci et al, 2017, Epigenetics CrossRef
3. Ethnicity and ERG frequency in prostate cancer
   Jason Sedarsky et al, 2018, Nature Reviews Urology CrossRef
4. Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer
   Francesca Lorenzin et al, 2022, Cancers CrossRef
5. A potential common role of the Jumonji C domain‑containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer
   Xiaomeng Li et al, 2018, Oncology Letters CrossRef
6. In-silico guided chemical exploration of KDM4A fragments hits
   Jessica Lombino et al, 2023, Clinical Epigenetics CrossRef
7. Activation of TC10-Like Transcription by Lysine Demethylase KDM4B in Colorectal Cancer Cells
   Baoyu Chen et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
8. SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer
   Sheng-You Liao et al, 2023, Nature Communications CrossRef
9. Engineering human JMJD2A tudor domains for an improved understanding of histone peptide recognition
   Jonathan Parkinson et al, 2023, Proteins: Structure, Function, and Bioinformatics CrossRef
10. The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities
    Guanjun Yang et al, 2024, Genes & Diseases CrossRef
11. Relationship between ETS Transcription Factor ETV1 and TGF-β-regulated SMAD Proteins in Prostate Cancer
    Sangphil Oh et al, 2019, Scientific Reports CrossRef
12. Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal Cancer
    Yuan Sui et al, 2020, Scientific Reports CrossRef
13. MicroRNA-137-mediated lysine demethylase 4A regulates the recovery of spinal cord injury via the SFRP4-Wnt/β-Catenin axis
    Wei Li et al, 2023, International Journal of Neuroscience CrossRef
14. Advances in histone demethylase KDM4 as cancer therapeutic targets
    Dong Hoon Lee et al, 2020, The FASEB Journal CrossRef
15. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases
    Xiaomeng Li et al, 2018, Molecular Medicine Reports CrossRef
16. Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of ADAM19 and KLF7
    Yuan Sui et al, 2023, Frontiers in Oncology CrossRef
17. Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis
    Ruicai Gu et al, 2023, Frontiers in Oncology CrossRef
18. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372
    Jiahui An et al, 2017, Oncotarget CrossRef
19. Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects
    Sander Frank et al, 2018, F1000Research CrossRef
20. Oncogenic ETS Factors in Prostate Cancer
    Taylor R. Nicholas et al, 2019, Prostate Cancer CrossRef
21. SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A
    Ruicai Gu et al, 2023, JCI Insight CrossRef